Settlement times ‒ Greece ‒ ATHEXCSD

20.03.2023

The deadlines shown below are valid provided that the customer's instructions are complete, accurate and eligible for straight-through processing (STP) in CBL and in the local market. Customers must also ensure that any necessary provision is available. If any of these criteria are not met, CBL cannot guarantee timely settlement.

Important Note: As part of CBL’s internal compliance procedures, all incoming customer instructions will be automatically scanned before entering transaction processing.  Instructions that are internally flagged as requiring further manual investigation are set to status pending, with such status immediately reported to the Customer via their chosen media channel(s), until either being manually released for processing or rejected.  In order to ensure that instructions being investigated do not miss the applicable deadlines, Customers are advised to input instructions at least 15 minutes before the associated deadline.

All times are Central European Time (CET).

InstructionProvisioningDeadline for receipt of valid instructionExpected settlement results
startendfromtovalue
AP=Against payment FOP=Free of payment SD=Settlement date
ATHEXCSD-eligible securities a
Receipts

FOP

15:00
SD-1
14:25
SD
14:25
SD
09:30
SD
18:00
SD

AP

19:30
SD-1
14:25
SD
14:25
SD
09:30
SD
18:00
SD

SD

Deliveries

FOP

15:00
SD-1
14:25
SD
14:25
SD
09:30
SD
18:00
SD

AP

15:00
SD-1
14:25
SD
14:25
SD
09:30
SD
18:00
SD

SD

a. Instructions transmitted after the CBL deadline but for the same requested settlement date may still settle on the requested settlement date.
A cancellation request received after the deadline will be processed on the next business day. However, matched transactions can only be cancelled by ATHEXCSD if both parties send cancellation instructions. OTC re-registration trades can be instructed, by the CBL deadline, on each SD  considering the T+2 settlement cycle. Information on the final beneficial owner is a matching criteria in ATHEXCSD and must be provided in each OTC re-registration instruction.